Independent fund research. Built on SEC filings.

How we research funds

ETF · Dividend & Equity Income · ProShares

ProShares S&P 500 Dividend Aristocrats ETF (NOBL)

Ticker NOBL · Index fund · · Holdings as of May 31, 2026

Expense ratio
0.35%$35/yr per $10k
5-yr return
+7.6%annualized
1-yr return
+6.9%as of Dec 2025
Net assets
$11.1Ball share classes
Holdings
74

Bottom line

Is NOBL a good fund? The bottom line

NOBL is an index dividend & equity income ETF from ProShares.

Its expense ratio is 0.35% — about $35 a year on every $10,000 invested, cheaper than 87% of dividend & equity income funds we track.

It returned +6.9% over one year, +7.6% a year over five years, +10.1% a year over ten (as of Dec 31, 2025, per its prospectus).

With $11.1 billion in net assets and 74 holdings, its largest position is Nucor Corp. (1.8%) and the top 10 make up 16.5% of the portfolio.

What stands out

  • Low cost: cheaper than 87% of dividend & equity income peers
  • Large and established ($11.1 billion)

What to watch

  • 5-year return in the bottom quarter of its category

Updated Nov 19, 2026

What NOBL invests in

ProShares S&P 500 Dividend Aristocrats ETF (the Fund) seeks investment results, before fees and expenses, that track the performance of the S&P 500 Dividend Aristocrats Index (the Index).

The Fund invests in financial instruments that ProShare Advisors believes, in combination, should track the performance of the Index. The Index is designed to measure the performance of companies in the S&P 500 Index that have consistently increased dividends each year for at least 25 years. The S&P 500 Index is designed to measure the performance of 500 of the largest companies listed and domiciled in the U.S. The Funds Index selects a minimum of 40 companies that have increased their dividends every year for at least 25 years. These companies are equally weighted in the Index, and no single sector is allowed to comprise more than 30% of the Index weight. If there are fewer than 40 companies with at least 25 consecutive years of dividend growth or if sector limits are breached, the Index will include companies with shorter dividend growth histories. The Indexs composition is…

From the fund's prospectus (filed Sep 25, 2026).

NOBL performance

Fund calendar-year total returns, 2016–2025 2016: +11.4%; 2017: +21.2%; 2018: −3.2%; 2019: +27.5%; 2020: +8.3%; 2021: +25.5%; 2022: −6.5%; 2023: +8.1%; 2024: +6.7%; 2025: +6.9% +11% 2016 +21% 2017 −3% 2018 +27% 2019 +8% 2020 +25% 2021 −7% 2022 +8% 2023 +7% 2024 +7% 2025
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
NOBL+6.9%+7.6%+10.1%
Dividend & Equity Income median+14.6%+10.1%+9.2%

Source: Fund prospectus, as of Dec 31, 2025

Full NOBL performance history →

What NOBL costs

On a $10,000 investment, NOBL's 0.35% expense ratio costs about $35 a year. The prospectus estimates $443 in total costs over 10 years (assuming 5% annual returns). The median dividend & equity income fund charges 0.74%.

See the full NOBL fee table →

NOBL top 10 holdings

#Holding% of fund
1Nucor Corp.1.76%
2West Pharmaceutical Services, Inc.1.72%
3International Business Machines Corp.1.71%
4Archer-Daniels-Midland Co.1.67%
5Franklin Resources, Inc.1.67%
6Colgate-Palmolive Co.1.61%
7Caterpillar, Inc.1.60%
8Automatic Data Processing, Inc.1.60%
9Hormel Foods Corp.1.60%
10JM Smucker Co. (The)1.58%

Source: SEC Form N-PORT, period ended May 31, 2026

The top 10 make up 16.5% of the fund. See all top 25 holdings and asset mix →

Alternatives to NOBL

More funds like NOBL →

NOBL FAQ

What is the expense ratio of NOBL?
NOBL's expense ratio is 0.35%, which works out to about $35 a year for every $10,000 invested. The prospectus estimates total costs of $443 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is NOBL a good investment?
It depends on your goals, but the data points to: low cost: cheaper than 87% of dividend & equity income peers; large and established ($11.1 billion); 5-year return in the bottom quarter of its category. This is general information, not personalized advice.
What does NOBL hold?
NOBL's largest holdings are Nucor Corp. (1.8%), West Pharmaceutical Services, Inc. (1.7%), International Business Machines Corp. (1.7%), Archer-Daniels-Midland Co. (1.7%), Franklin Resources, Inc. (1.7%). It holds 74 positions in total as of May 31, 2026 (SEC Form N-PORT).
What is NOBL's 5-year return?
NOBL returned +7.6% a year over the five years ending Dec 31, 2025, and +10.1% a year over ten years. Past performance does not guarantee future results.
Who manages NOBL?
NOBL is offered by ProShares through Proshares Trust.